533 related articles for article (PubMed ID: 8141817)
1. Effects of the new calcium antagonist monatepil on cardiac function and myocardial oxygen supply and demand in animals.
Kataoka T; Nose I; Honda Y; Yamada T; Hatano N; Masuda Y; Hosoki K; Karasawa T
Arzneimittelforschung; 1993 Dec; 43(12):1303-9. PubMed ID: 8141817
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo electrocardiographic evaluation of the novel calcium antagonist monatepil on cardiac conduction system.
Nose I; Kataoka T; Honda Y; Yamada T; Ikeno A; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T
Arzneimittelforschung; 1993 Jul; 43(7):722-8. PubMed ID: 8369002
[TBL] [Abstract][Full Text] [Related]
3. Preventive effect of monatepil on thromboxane A2 agonist-induced myocardial ischemia in rats.
Yamamoto T; Hosoki K; Kikuta C; Karasawa T
Arzneimittelforschung; 1994 Jun; 44(6):712-4. PubMed ID: 8053969
[TBL] [Abstract][Full Text] [Related]
4. Cardiac action of KB-944, a new calcium antagonist.
Morita T; Ito K; Nose T
Arzneimittelforschung; 1982; 32(9):1053-5. PubMed ID: 6890825
[TBL] [Abstract][Full Text] [Related]
5. Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys.
Miyazaki M; Hosoki K; Okunishi H; Ishii K; Ikeno A; Okazaki Y
Arzneimittelforschung; 1994 Mar; 44(3):288-97. PubMed ID: 8192692
[TBL] [Abstract][Full Text] [Related]
6. Studies on calcium antagonistic and alpha 1-adrenergic receptor blocking activities of monatepil maleate, its metabolites and their enantiomers.
Honda Y; Masuda Y; Yoshida T; Sato F; Kurokawa M; Hosoki K
Arzneimittelforschung; 1995 Oct; 45(10):1057-60. PubMed ID: 8595057
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular actions of the dihydropyridine calcium antagonist nimodipine in the dog.
Satoh K; Kawada M; Wada Y; Taira N
Arzneimittelforschung; 1984; 34(5):563-8. PubMed ID: 6540573
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs.
Beaughard M; Michelin MT; Tisne-Versailles J; Lamar JC
Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):276-96. PubMed ID: 3493742
[TBL] [Abstract][Full Text] [Related]
9. [Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study].
Veit S; Brückner JB; Vogt K; Wagner R; Hess W
Z Kardiol; 1985 Feb; 74(2):76-84. PubMed ID: 3993153
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
[TBL] [Abstract][Full Text] [Related]
11. Effects of nipradilol (K-351) on cardiac function in anesthetized open-chest dogs.
Sakanashi M; Noguchi K; Takeo S; Ito H; Miyamoto Y; Kato T
Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):47-55. PubMed ID: 2861795
[TBL] [Abstract][Full Text] [Related]
12. Effects of niguldipine, a new dihydropyridine calcium antagonist, on regional blood flow, cardiac performance and myocardial metabolism in anaesthetized open-chest dogs.
Fischer G; Schneider W; Krumpl G; Grohs JG; Raberger G
Arch Int Pharmacodyn Ther; 1989; 298():96-107. PubMed ID: 2757470
[TBL] [Abstract][Full Text] [Related]
13. Vasodilator action of KB-944, a new calcium antagonist.
Morita T; Yoshino K; Kanazawa T; Ito K; Nose T
Arzneimittelforschung; 1982; 32(9):1037-42. PubMed ID: 6890822
[TBL] [Abstract][Full Text] [Related]
14. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
[TBL] [Abstract][Full Text] [Related]
15. Long-lasting antagonistic effects of monatepil on Ca2+ current in guinea-pig ventricular cells.
Nagata S; Hosoki K; Karasawa T
Arzneimittelforschung; 1995 Oct; 45(10):1061-3. PubMed ID: 8595058
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs.
Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R
J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761
[TBL] [Abstract][Full Text] [Related]
17. Effects of magnesium chloride on cardiovascular hemodynamics in the neurally intact dog.
Friedman HS; Nguyen TN; Mokraoui AM; Barbour RL; Murakawa T; Altura BM
J Pharmacol Exp Ther; 1987 Oct; 243(1):126-30. PubMed ID: 3668845
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of the new calcium antagonist isradipine and of diltiazem in anesthetized open-chest dogs.
Sakanashi M; Miyamoto Y; Noguchi K; Kato T; Matsuzaki T; Miyagi H; Ikema S; Kinjo N
Arzneimittelforschung; 1988 Dec; 38(12):1792-6. PubMed ID: 2977545
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic heart rate reduction: effect of a novel, specific bradycardic agent on the heart.
Granetzny A; Schwanke U; Schmitz C; Arnold G; Schäfer D; Schulte HD; Gams E; Schipke JD
Thorac Cardiovasc Surg; 1998 Apr; 46(2):63-9. PubMed ID: 9618805
[TBL] [Abstract][Full Text] [Related]
20. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
